FACS analysis showed that the population of B10 cells (CD19+CD24+CD38+IL-10+) was significantly larger in the blood of patients with GC compared with controls (14.5 and 4.85, respectively, P < 0.01, Fig. 1). This evidence concerns the gene CD19 and gastric cancer.